NASDAQ:GLPG
Galapagos NV Stock News
$28.76
+0.130 (+0.454%)
At Close: Apr 26, 2024
7 Biotech Stocks to Buy and Hold in 2020
02:31pm, Monday, 16'th Mar 2020
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
Hedge Funds Have Never Been This Bullish On HEICO Corporation (HEI)
11:25pm, Wednesday, 11'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published this article and predicted that US stocks will go down by at least 20% in the next 3-6
Best & Worst ADRS - Monday, March 9
05:22pm, Monday, 09'th Mar 2020
The top-ranked sectors are utilities and technology. Healthcare, consumer goods, and basic materials rank neutral.
5 Biotech Stocks to Buy for a Strong Growth Prognosis
11:10am, Friday, 06'th Mar 2020
The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics
09:56pm, Tuesday, 03'rd Mar 2020
When Novartis signed on as a partner to Pliant Therapeutics last fall, it also agreed to eventually take an equity stake in the smaller biotech. The Swiss
Galapagos Ratings Downgrade, And Other News: The Good, Bad And Ugly Of Biopharma
09:35pm, Wednesday, 26'th Feb 2020
Galapagos was down on a ratings downgrade. Insmed misses Q4 EPS. Perrigo gets an approval.
Analysts Conflicted on These Healthcare Names: Galapagos (GLPG), Allergan (AGN) and Puma Biotechnology (PBYI)
09:37am, Tuesday, 25'th Feb 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG), Allergan (AGN) and Puma Biotechnology
7 Stocks to Buy Over $100 That Are Worth Their Price Tags
04:14pm, Monday, 24'th Feb 2020
Not all high-priced stocks have earned their valuations. But these seven stocks to buy are great despite their price tags.
Sell-siders cut views on Tivity Health after ugly Q4
12:25pm, Thursday, 20'th Feb 2020
Hutchison China MediTech (NASDAQ:HCM) initiated with Buy rating and $38 (38% upside) price target at Goldman Sachs.Eidos Therapeutics (NASDAQ:EIDX) initiated with Buy rating and $66 (27% upside) price
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
Another Possible Source Of Alpha
11:37pm, Friday, 14'th Feb 2020
Last month, I showed the performance of a new version of my system's security selection method. Here, I update the performance of that security selection method
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
02:18pm, Wednesday, 12'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NAS
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN )
Ziopharm Secondary, And Other News: The Good, Bad And Ugly Of Biopharma
11:10pm, Monday, 10'th Feb 2020
Ziopharm announced a dilutive secondary share offering. Gilead's earnings call and new strategy. Celsion has new safety data.
